ASSET | DATE | % RETURN |
---|---|---|
Amicus Therapeutics (FOLD) | 5/1/2014 - 12/31/2014 | 273.09% |
TG Therapeutics (TGTX) | 5/1/2014 - 12/31/2014 | 199.43% |
Willdan (WLDN) | 5/1/2014 - 12/31/2014 | 191.99% |
PTC Therapeutics (PTCT) | 5/1/2014 - 12/31/2014 | 167.13% |
Agios Pharm (AGIO) | 5/1/2014 - 12/31/2014 | 161.78% |
EXACT Sciences (EXAS) | 5/1/2014 - 12/31/2014 | 142.62% |
Ionis Pharmaceuticals (IONS) | 5/1/2014 - 12/31/2014 | 129.26% |
Amedisys (AMED) | 5/1/2014 - 12/31/2014 | 115.49% |
Ambarella (AMBA) | 5/1/2014 - 12/31/2014 | 103.69% |
Marcus & Millichap (MMI) | 5/1/2014 - 12/31/2014 | 101.15% |
MiMedx (MDXG) | 5/1/2014 - 12/31/2014 | 100.17% |
Xenon Pharmaceuticals (XENE) | 5/1/2014 - 12/31/2014 | 97.11% |
Qorvo (QRVO) | 5/1/2014 - 12/31/2014 | 96.1% |
Alnylam Pharmaceuticals (ALNY) | 5/1/2014 - 12/31/2014 | 95.96% |
Qualys (QLYS) | 5/1/2014 - 12/31/2014 | 95.39% |
Xpel (XPEL) | 5/1/2014 - 12/31/2014 | 94.89% |
JetBlue Airways (JBLU) | 5/1/2014 - 12/31/2014 | 94.6% |
Ensign (ENSG) | 5/1/2014 - 12/31/2014 | 93.97% |
Palo Alto Networks (PANW) | 5/1/2014 - 12/31/2014 | 91.82% |
Cimpress (CMPR) | 5/1/2014 - 12/31/2014 | 89.85% |
Enphase Energy (ENPH) | 5/1/2014 - 12/31/2014 | 89.02% |
eXp World (EXPI) | 5/1/2014 - 12/31/2014 | 84.48% |
Phibro Animal Health (PAHC) | 5/1/2014 - 12/31/2014 | 84.47% |
Ocular Therapeutix (OCUL) | 5/1/2014 - 12/31/2014 | 80.92% |
ANI Pharmaceuticals (ANIP) | 5/1/2014 - 12/31/2014 | 80.74% |